No Data
No Data
Chuan Ning Biotech (301301.SZ): 2023 equity distribution, 10 distributions of 2.25 yuan, share registration date May 21
On May 15, Ge Longhui Biotech (301301.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 2.24,5595 (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 2,227,160,000 shares. The share registration date for this equity distribution is May 21, 2024, and the ex-dividend date is May 22, 2024.
Chuan Ning Biology (301301.SZ): Currently not cooperating with Jiangnan University
Gelonghui, May 14, 丨 Channing Biology (301301.SZ) said on the investor interactive platform that the company has not yet cooperated with Jiangnan University. The company has set up a research institute in Shanghai, and also has cooperative projects with various biological research institutes and well-known universities such as the Institute of Microbiology of the Chinese Academy of Sciences, the Tianjin Institute of Industrial Biotechnology, and East China University of Technology.
Twining Biology (301301.SZ): Currently, some synthetic biology products are produced at the “synthetic biology production base”
Gelonghui, May 14, 丨 Chuan Ning Biology (301301.SZ) said on the investor interactive platform that the company currently produces some synthetic biology products at the “synthetic biology production base”, such as bisabolol, 5-hydroxytryptophan, etc.; at the same time, some products have already entered the small test and pilot phase, such as: squalane, ergothione, inositol, ecdoine, etc.; currently, the Shanghai Research Institute continues to step up research and development efforts to actively promote the delivery of new synthetic biology products.
Express News | Twining Biotech: The company's daily business situation and internal and external production and operation environment have not changed significantly compared to before abnormal fluctuations
Dragon Tiger List丨Chuan Ning Biotech climbed more than 81% on the 5th, and today's net sales of 435 million yuan were on the list
Glonghui, May 8 | Chuan Ning Biotech (301301.SZ) rose 4.78% to a record high today, with a turnover of 3.133 billion yuan and a turnover rate of 29.55%; in the five trading days from April 29 to now, the stock has risen more than 81%. According to data from the Dragon Tiger List, Oriental Securities sold one seat, with a net sales of 233 million yuan; the Shanghai branch of Changjiang Securities sold three seats, with net sales of 129 million yuan; and Shenwan Hongyuan's Chengdu West First Ring Road Sales Department sold four seats, with net sales of 119 million yuan. Seats on the list bought 510 million yuan and sold 946 million yuan throughout the day, a total net
Twining Biotech traded a net sale of 603.495 million yuan today
Chuan Ning Biotech went up and down today, with a turnover of 2,136 billion yuan and a turnover rate of 22.56%. After the market, Dragon Tiger Index data showed that the Shenzhen Stock Connect exclusive seat bought 33.0815 million yuan and sold 56.1749 million yuan, with a net sale of 60.3495 million yuan.
No Data